» Articles » PMID: 24581432

Use of Omalizumab to Improve Desensitization Safety in Allergen Immunotherapy

Overview
Date 2014 Mar 4
PMID 24581432
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Allergen Immunotherapy for the Prevention and Treatment of Asthma.

Batard T, Taille C, Guilleminault L, Bozek A, Bordas-Le Floch V, Pfaar O Clin Exp Allergy. 2024; 55(2):111-141.

PMID: 39363801 PMC: 11791393. DOI: 10.1111/cea.14575.


Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways.

Eggel A, Pennington L, Jardetzky T Immunol Rev. 2024; 328(1):387-411.

PMID: 39158477 PMC: 11659931. DOI: 10.1111/imr.13380.


EAACI Allergen Immunotherapy User's Guide.

Alvaro-Lozano M, Akdis C, Akdis M, Alviani C, Angier E, Arasi S Pediatr Allergy Immunol. 2020; 31 Suppl 25:1-101.

PMID: 32436290 PMC: 7317851. DOI: 10.1111/pai.13189.


The future outlook on allergen immunotherapy in children: 2018 and beyond.

Arasi S, Corsello G, Villani A, Pajno G Ital J Pediatr. 2018; 44(1):80.

PMID: 29996875 PMC: 6042356. DOI: 10.1186/s13052-018-0519-4.


Impact of allergen immunotherapy in allergic asthma.

Zhang W, Lin C, Sampath V, Nadeau K Immunotherapy. 2018; 10(7):579-593.

PMID: 29569506 PMC: 5994829. DOI: 10.2217/imt-2017-0138.